The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Oct. 07, 2010
Applicants:

Kazuhide Ohta, Osaka, JP;

Hiroshi Miyamoto, Tokushima, JP;

Junji Takaba, Osaka, JP;

Ako Nosé, Houston, TX (US);

Inventors:

Yukihiko Nosé, Houston, TX (US);

Kazuhide Ohta, Osaka, JP;

Hiroshi Miyamoto, Tokushima, JP;

Junji Takaba, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); A61M 1/36 (2006.01); A61K 31/727 (2006.01); A61M 1/14 (2006.01); A61K 31/135 (2006.01); A61M 1/34 (2006.01); B01J 20/00 (2006.01); B01D 15/00 (2006.01); B01J 20/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/727 (2013.01); A61M 1/3621 (2013.01); A61M 1/16 (2013.01); A61M 1/14 (2013.01); A61K 31/135 (2013.01); A61M 1/3496 (2013.01); B01J 20/00 (2013.01); A61M 1/3486 (2014.02); B01D 15/00 (2013.01); B01J 20/22 (2013.01); B01J 2220/4825 (2013.01); B01J 2220/4831 (2013.01);
Abstract

The invention provides a way of producing a natural immunologically active state in a person by subjecting him to an apheresis procedure with bioincompatible biomaterials for about one hour. To safely control the immunological shock induced by this procedure, the person is put under general anesthesia for about six hours, including the apheresis time and at least an additional five hours thereafter. This immunological activation is useful for treating malignant tumors and diseases related to immunosuppression, such as AIDS. The invention also provides for the use of an apheresis column containing a blood perfusion filter with bioincompatible materials for treating malignant tumors and infectious diseases.


Find Patent Forward Citations

Loading…